• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, July 29, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

Control HIV by treating schistosomiasis, new study suggests

Bioengineer by Bioengineer
December 16, 2018
in Immunology
Reading Time: 3 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Wetzel and Shaefer, Wikimedia Commons, Public Domain, 2001


Of the 34 million people worldwide with HIV, and the 200 million with schistosomiasis, the majority live in Africa– where millions of people are simultaneously infected with both diseases. Now, researchers reporting in PLOS Neglected Tropical Diseases have shown that schistosomiasis infections are associated with increased HIV onward transmission, HIV acquisition in HIV negative women with urogenital schistosomiasis, and progression to death in HIV positive women.

Schistosomiasis is caused by a parasitic worm and is second only to malaria in terms of parasitic diseases with the most global health impact. Schistosomiasis may cause lesions in the genital tract and has been shown–in cross-sectional studies– to be associated with HIV prevalence.

In the new work, Dr. Kristin Wall, of Emory University, USA, and colleagues retrospectively tested the blood sera of 2,145 people enrolled in a cohort of HIV-discordant heterosexual couples in Zambia. Each sample was measured for schistosome-specific antibody levels. In addition, health information including HIV status over time and death was available for the cohort.

59% of all participants were positive for a schistotome-specific antibody response. Among men and women positive for HIV, baseline response for schistosomiasis was associated with an increased risk of transmitting HIV to their uninfected partner. In addition, among women, schistosomiasis was associated with increased acquisition of HIV (in HIV negative women with urogenital schistosomiasis) and increased progression to death (in HIV positive women).

“Since treatment of schistosome infections with praziquantel is inexpensive, effective, and safe, schistosomiasis prevention and treatment strategies may be a cost-effective way to reduce not only the symptoms associated with the infection, but also new cases of HIV and death among HIV+ persons,” the researchers say.

###

In your coverage please use this URL to provide access to the freely available paper: http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006902

Citation: Wall KM, Kilembe W, Vwalika B, Dinh C, Livingston P, et al. (2018) Schistosomiasis is associated with incident HIV transmission and death in Zambia. PLOS Neglected Tropical Diseases 12(12): e0006902. https://doi.org/10.1371/journal.pntd.0006902

Funding: This work was supported by the Bill and Melinda Gates Foundation [Grant ID 1005342], the National Institute of Child Health and Development [NICHD R01 HD40125]; National Institute of Mental Health [NIMH R01 66767]; the AIDS International Training and Research Program Fogarty International Center [D43 TW001042]; the Emory Center for AIDS Research [P30 AI050409]; National Institute of Allergy and Infectious Diseases [NIAID R01 AI51231, NIAID R01 AI040951, NIAID R01 AI023980, NIAID R01 AI64060, NIAID R37 AI51231]; the US Centers for Disease Control and Prevention [5U2GPS000758]; and the International AIDS Vaccine Initiative. This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents do not necessarily reflect the views of USAID, CDC, or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared no competing interests exist.

Media Contact
Kristin Wall
[email protected]

Original Source

http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006902

Related Journal Article

http://dx.doi.org/10.1371/journal.pntd.0006902

Tags: AIDS/HIVBiologyDisease in the Developing WorldInfectious/Emerging DiseasesMedicine/HealthMolecular BiologyParasitologyVirology
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

UMass Amherst grad student awarded fellowship for food allergy research

July 23, 2021
IMAGE

Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested

July 22, 2021

Public trust in CDC, FDA, and Fauci holds steady, survey shows

July 20, 2021

USC study shows male-female differences in immune cell function

July 19, 2021
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    54 shares
    Share 22 Tweet 14
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    42 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    45 shares
    Share 18 Tweet 11
  • Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Novel Plasma Synuclein Test Advances Parkinson’s Diagnosis

Advancing Microbial Risk Assessment Through Detection Technology Evolution

Obesity’s Impact on Pancreatic Surgery Outcomes Compared

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.